Blood culture is defined as the microbiological culture of blood, to detect infections that are spreading through the bloodstream. The infections spreading through the blood stream include bacteremia and septicemia among others. This is possible because the bloodstream is usually a sterile environment. Negative effect of an improper blood culture includes risks of wrong venipuncture and the occurrence of false positive results. This phenomenon has been observed in over 3% of the blood culture cases and could hamper patient safety through inappropriate diagnosis and treatment. Globally, bloodstream infections (BSI) one of the leading cause of morbidity and mortality, and associated with significant healthcare costs. It has been estimated that approximately 1 million patients in the U.S. are diagnosed with BSI, costing the healthcare system nearly US$ 1 billion.
Blood Culture Test Market: Drivers and Restraints
Drivers for the blood culture test market include high incidence of blood stream infections, rising demand for rapid diagnostic tests, a large percentage of aging population across countries apart from rapid advancements in medical technology, growing awareness among the patients and increasing adoption rate of the latest technologies among patients. Some of the latest technologies for blood culture test include multiplex real-time PCR system, use of molecular method, mass spectrometry & electro spray ionization.
Browse Full Report@ http://www.futuremarketinsights.com/reports/blood-culture-test-market
Restraints for the market include high cost of advanced blood culture techniques and lack of appropriate reimbursement policies. Further, lack of proper training among medical technicians in developing countries and other resource-poor nations is also expected to hamper the revenue growth of the market.
Blood Culture Test Market: Segmentation
Blood Culture Test market can be segmented into these following ways:...